FDAnews Drug Daily Bulletin
Pharmaceuticals / Regulatory Affairs

Torrent Expands Losartan Recall

April 30, 2019
A A

Torrent Pharmaceuticals expanded the recall of its losartan potassium and losartan potassium/hydrochlorothiazide tablets to include another 104 lots.

The newly added lots expand a recall that began last year when tests revealed cancer-causing N-Nirtoso-N-methyl-4-aminobutyric acid (NMBA). Just last month, Torrent recalled 87 other losartan lots.

The products were distributed nationwide to Torrent’s wholesale distributor, repackager and retail customers. Patients are being advised to continue taking their blood pressure pills until they can get a replacement drug.

View today's stories